Word: schwartze
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Yard, but also affords many groups the opportunity to hear and think about the effects of sexual violence on campus and off. The Undergraduate Council passed legislation on Sunday supporting “Take Back the Night” and encouraging representatives to attend the event. Yesterday Benjamin P. Schwartz ’10, the vice-chair of the UC’s Committee on College Life, came to show his support. “Without using our role as student advocates to help raise awareness, we fail our constituents,” he said. “When...
...create a virtual campus,” said Benjamin P. Schwartz ’10, one of the site’s co-founders. “We don’t just want a student Web portal, we want a student...
...something that creepy while still seeming like a really nice guy. The same innocent charm made him an US magazine fixture as The O.C's breakout star: the sarcastic but decent one. "Adam is the funniest guy you still want to see get the girl," says O.C. creator Josh Schwartz, 30, who patterned Brody's character after himself. "He's able to attract neurotic Jewish writers to write for him, but he's definitely cooler in real life than the characters he's provided. He can be really sweet and adorkable, but there's some anger there. He was able...
Brody does, in fact, have a kind of geeky weirdness, a slight awkwardness on top of his mellow self-deprecating charm that Schwartz says manifests itself, for instance, when he transforms, as he does often, into a "monologuist movie reviewer." Or you can see it in his thwarted dream to produce a remake of Revenge of the Nerds. Or, as the neurotic Jewish first-time writer-director of In the Land of Women, Jon Kasdan (son of Big Chill director Lawrence Kasdan), says, "He's a new kind of nerdy Jewish guy: both self-deprecating and self-possessed...
...everyone is convinced by that logic. Dr. Robert Schwartz, an editor at the New England Journal of Medicine, says, "Using patients as their own control is a bit shaky, especially for follicular lymphoma." A Phase III randomized trial, more difficult but still possible to conduct even with customized vaccines remains, he says, "the gold standard for proof of efficacy." Dr. Kwak, who is conducting his own Phase III trial of a vaccine for the American pharmaceutical company Biovest, believes his former trainee's results support the case for a therapeutic lymphoma vaccine, but is skeptical about his methods. "Dr. Bendandi...